You are required to be logged in to access the full website
Click here if you have forgotten your username or password
19 June 2013 - 19 June 2013 - US biopharmaceutical company PhaseBio announced on Tuesday that it has completed a Phase I clinical trial of Vasomera (PB1046) for cardiopulmonary diseases treatment and that it has initiated a second Phase I study.The s...
19 June 2013 - 19 June 2013 - US diagnostic solutions company Gold Standard Diagnostics revealed today its new Line Immunoassay technology for Lyme disease testing.Thanks to its latest addition, Gold Standard will provide laboratories with an US FDA-...
19 June 2013 - 19 June 2013 - BD Biosciences, a unit of Becton, Dickinson and Company (NYSE:BDX), or BD, said today it had introduced its latest research flow cytometer, the BD LSRFortessa X-20 Cell Analyzer.The compact product can be configured with...
19 June 2013 - 19 June 2013 - Canadian biotech group iCo Therapeutics Inc (CVE:ICO) said Tuesday it had finalised the patient enrolment in a Phase II study of its second-generation antisense inhibitor targeting C-raf (ribonucleic acid-mRNA), iCo-007,...
19 June 2013 - 19 June 2013 - Irish Amarin Corporation plc (NASDAQ:AMRN) said today it had been notified that a US FDA advisory committee will meet on 16 October regarding the supplemental New Drug Application (sNDA) for Vascepa (icosapent ethyl) cap...
M2 Pharma brings you breaking news and information on the
global pharmaceuticals industry, helping you to stay one step ahead of the competition.
Click here to subscribe
Click here to subscribe